Miriam Isola

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

Salvatore De Vita, Luca Quartuccio, Miriam Isola et al. · Arthritis & Rheumatism · 2011 · 399 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients

Maddalena Peghin, Alvisa Palese, Margherita Venturini et al. · Clinical Microbiology and Infection · 2021 · 326 citations · Full text

Veterinary Medicine, Clinical Sciences, Infectious Diseases +5

Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients

Tamara Ius, Miriam Isola, Riccardo Budai et al. · Journal of neurosurgery · 2012 · 292 citations · Full text

Medicine, Neurosurgery, Surgery +16

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

Francesco Zaja, Michele Baccarani, Patrizio Mazza et al. · Blood · 2010 · 259 citations

Life Sciences, Immunology, Pharmacotherapy +7

Preliminary classification criteria for the cryoglobulinaemic vasculitis

Salvatore De Vita, Franca Soldano, Miriam Isola et al. · Annals of the Rheumatic Diseases · 2011 · 156 citations · Full text

Natural Sciences, Biophysics, Hematology +17